Replies to post #321051 on Avid Bioservices Inc (CDMO)

[vieuxcarre]

WHO CARES, THE COMP IS A CDMO NOW
ANY REFERENCE TO TRIALS IS IRRELEVANT

Phase II exceeded the placbo by 109% MOS improvement and Peregrine filed for phase III based upon 60% MOS conservative improvement of MOS

So you see....where does it say they set up phase III to equal performance of placebo ? Lol sounds like some non truths in your opinion

[The Other Guy]

Phase 2 data was never audited externally. Failure after failure by King and the old BOD.